ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $10.49, but opened at $9.90. ASP Isotopes shares last traded at $10.17, with a volume of 2,369,388 shares trading hands.
Analyst Ratings Changes
Separately, Canaccord Genuity Group upped their target price on ASP Isotopes from $8.50 to $11.00 and gave the company a "buy" rating in a report on Wednesday, May 21st.
Check Out Our Latest Stock Analysis on ASPI
ASP Isotopes Trading Down 3.4%
The firm has a market capitalization of $810.23 million, a PE ratio of -15.84 and a beta of 3.35. The company has a current ratio of 7.21, a quick ratio of 7.17 and a debt-to-equity ratio of 0.80. The business has a fifty day moving average price of $7.96 and a two-hundred day moving average price of $6.13.
Institutional Trading of ASP Isotopes
Hedge funds have recently made changes to their positions in the business. PFG Investments LLC raised its position in shares of ASP Isotopes by 32.5% during the 2nd quarter. PFG Investments LLC now owns 26,500 shares of the company's stock worth $195,000 after acquiring an additional 6,500 shares in the last quarter. Perennial Advisors LLC purchased a new stake in ASP Isotopes during the second quarter worth approximately $110,000. Farther Finance Advisors LLC purchased a new stake in ASP Isotopes during the second quarter worth approximately $707,000. Harbour Capital Advisors LLC purchased a new stake in ASP Isotopes during the second quarter worth approximately $232,000. Finally, Exchange Traded Concepts LLC purchased a new stake in ASP Isotopes during the second quarter worth approximately $9,593,000. Institutional investors and hedge funds own 16.80% of the company's stock.
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.
Read More
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
